Form 8-K - Current report:
SEC Accession No. 0001641172-25-003602
Filing Date
2025-04-10
Accepted
2025-04-10 16:05:11
Documents
13
Period of Report
2025-04-03
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 33432
  Complete submission text file 0001641172-25-003602.txt   202184

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE gcan-20250403.xsd EX-101.SCH 3003
3 XBRL LABEL FILE gcan-20250403_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE gcan-20250403_pre.xml EX-101.PRE 24157
15 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3357
Mailing Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208
Business Address 15 WALKER AVE, SUITE 101 BALTIMORE MD 21208 (443) 738-4051
Greater Cannabis Company, Inc. (Filer) CIK: 0001695473 (see all company filings)

EIN.: 300842570 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-56027 | Film No.: 25828348
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)